Summit Therapeutics Inc.
- Last sale
- Nov 12, 2026 · -9.32%
- Market cap
- $12.06B
- 799.76M shares
- Filings
- 568
FY 2024
Q3 2026N/M FY25 yoy
FY 2024N/M FY24 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026+114.8% FY25 yoy
- $12.06B
- —
- —
- 21.4×
- -2.68%
- —
FY2025 figures · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2024 | 2024-12-31 | $0 | reported | |
| FY 2023 | 2023-12-31 | $0 | reported | |
| FY 2022 | 2022-12-31 | $705,000 | reported | |
| FY 2021 | 2021-12-31 | $1,809,000 | reported | |
| FY 2020 | 2020-12-31 | $860,000 | reported | |
| FY 2019 | 2019-12-31 | $743,000 | reported | |
| FY 2018 | 2019-01-31 | $57,088,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2020 | $0.00 | — | $0.00 | — | 82.92M sh | −75.3% | — |
| FY2019 | $0.00 | — | $0.00 | — | 335.89M sh | +356.6% | — |
| FY2018 | $0.00 | — | $0.00 | — | 73.56M sh | — | — |
Segments
LineFY2022ShareChange
Latin America$705.00K100%−61.0%
Europe———
United States———
Total$705.00K
Pharmaceutical preparations
Summit Therapeutics Inc. is the 29th largest of the 552 covered companies the SEC files under this code, by market cap. SIC 2834
CompanyRevenueGrowthNet marginMarket cap
KNSAKiniksa Pharmaceuticals International, plc$677.6M60.1%8.7%$15.1BBBIOBridgeBio Pharma, Inc.$502.1M126.3%144.4%$14.6BELANElanco Animal Health Inc$4.7B6.2%4.9%$13.3BRDYDr Reddys Laboratories LtdFiscal 2025 figures———$12.3B
SMMTSummit Therapeutics Inc. (this company)———$12.1B
BMRNBioMarin Pharmaceutical Inc$3.2B12.9%10.8%$11.0BMDGLMadrigal Pharmaceuticals, Inc.$958.4M432.1%30.1%$9.9BSYRESpyre Therapeutics, Inc.$0.0——$9.8BTGTXTG Therapeutics, Inc.$616.3M87.3%72.6%$9.8BPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in market cap first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Summit Therapeutics Inc. · CIK 1599298 · Engraved from SEC EDGAR